Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/1999
03/23/1999US5885621 Administering a therapeutic gas to the patient, wherein the therapeutic gas comprises a therapeutically effective amount of gaseous nitric oxide (no); sickle cell anemia
03/23/1999US5885574 Antibodies which activate an erythropoietin receptor
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999CA2130878C 4-aminopyrimidine derivatives
03/23/1999CA2096293C Alkene carboxylic acid derivatives, method of preparation thereof and pharmaceutical compositions containing them
03/23/1999CA2008771C Pyridinium nitrate, its production and use
03/23/1999CA1340463C Alkanophenones
03/18/1999WO1999013076A1 Mpl ligand analogs
03/18/1999WO1999012936A1 Furopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012935A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012932A1 Method of inhibiting serine protease enzymes
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012921A1 Thromboxane ligands
03/18/1999WO1999012903A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
03/18/1999WO1998057937A3 Inhibitors of factor xa with a neutral p1 specificity group
03/18/1999CA2303480A1 Mpl ligand analogs
03/18/1999CA2303438A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302555A1 Thromboxane ligands
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
03/17/1999EP0675899B1 NOVEL INHIBITORS OF FACTOR Xa
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211280A Thrombin muteins as antidotes for thrombin inhibitors
03/17/1999CN1211232A Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
03/16/1999US5883126 Pharmacological use of certain cystine derivatives
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883107 Antithrombotic agents
03/16/1999US5883100 Benzamidine derivatives and their use as anti-coagulants
03/16/1999US5883078 Hemostyptic and tissue adhesive
03/16/1999US5883077 Peptides aldehyde analogues
03/16/1999US5882914 Nucleic acids encoding the hypoxia inducible factor-1
03/16/1999US5882887 Proteins for genetic engineering
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882674 Transdermal therapeutic system comprising active substances representing carbon monoxide sources
03/11/1999WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011267A1 Pyrazinone thrombin inhibitors
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011263A1 Combination therapy comprising amlodipine and a statin compound
03/11/1999WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin
03/11/1999WO1999011256A1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999CA2303476A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2301520A1 Pyrazinone thrombin inhibitors
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900235A1 Fragments of cr1 and their use
03/10/1999EP0900207A1 Pyrazinone thrombin inhibitors
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0681590B1 Anticoagulant composition
03/10/1999EP0677039B1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
03/10/1999CN1042430C N-alkyl-2-substituted ATP anologues, preparation and use thereof
03/09/1999US5880284 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/09/1999US5880265 Isolating factor viii and recombinants by anion exchange chromotography resulting in highly pure von willebrand factor having structural integrity, stability and no proteolytic degradation
03/09/1999US5880263 Human chemotactic protein
03/09/1999US5880256 Inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of factor viia, factor xia, plasma kallikrein, or plasmin is indicated.
03/09/1999US5880152 Inflammatory bowel disease
03/09/1999US5880136 Sulfonamide fibrinogen receptor antagonists
03/09/1999US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome
03/09/1999US5879677 Method for inhibition of cerebral tissue factor mediated reperfusion damage
03/09/1999US5879673 Administration of thrombopoietin on a single day only
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010494A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
03/04/1999WO1999010371A2 Cyclopeptide derivatives as adhesion inhibitors
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1998055506A3 Thrombin-inhibiting peptide
03/04/1999WO1998055074A3 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
03/04/1999CA2301182A1 Cyclopeptide derivatives
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0898965A2 Use of tetrahydrofolates for modulating the homocysteine level
03/03/1999EP0898559A2 Cytoprotective compounds
03/03/1999CN1209751A Improved concentrated injection and infusion solutions for intravenous administration
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877289 Tissue factor compositions and ligands for the specific coagulation of vasculature
03/02/1999US5877213 Compositions and methods for therapy and prevention of cancer, AIDS, and anemia
03/02/1999US5877181 Benzamidine derivatives and their use as anti-coagulants
03/02/1999US5877155 Exposure of platelets to the molecule (anti-mimotope) in order to modulate adhesion, aggregation, or agglutination of the platelets.
03/02/1999US5877153 Heparin-binding peptides
03/02/1999US5877152 Method for isolation of highly pure von Willebrand Factor
03/02/1999US5877006 DNAs encoding chimeric immunoglobulin light or heavy chains and fragments thereof having variable regions derived from monoclonal antibody 7E3, and vectors and host cells comprising same
03/02/1999US5876971 Amino acid sequence of protein isolated from insects which suck the blood of mammals; anticoagulants; treatment of thromboses or unstable angina or arteriosclerosis; prevention of reblockage of vessels after angioplasty
03/02/1999US5876968 Mixture of disulfide bonded dimer of al-milano, lipid lowering agent, and carrier; drug for treatment of athlerosclerosis and cardiovascular disease; prodrug for monomer; prevention of thrombosis
02/1999
02/25/1999WO1999009152A1 Human frezzled-like protein
02/25/1999WO1999009061A1 Secreted proteins
02/25/1999WO1999009052A1 Chemical modification of proteins to improve biocompatibility and bioactivity
02/25/1999WO1999009027A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors
02/25/1999WO1999009024A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
02/25/1999WO1999008729A1 Loading and release of water-insoluble drugs
02/25/1999WO1999008718A2 Bioresorbable compositions for implantable prostheses
02/25/1999WO1999008525A1 Methods for lowering platelet counts
02/25/1999WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases
02/25/1999DE19736772A1 New guanidino-substituted bi:cyclic peptide compounds
02/25/1999CA2301806A1 Methods for lowering platelet counts
1 ... 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 ... 671